XML 46 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue recognition (Tables)
9 Months Ended
Sep. 30, 2018
Revenue from Contract with Customer [Abstract]  
Contract liabilities, rollforward and revenue recognition
During the three and nine months ended September 30, 2018, the Company recognized revenue in the period from:
 
 
Three Months Ended September 30, 2018
 
Nine Months Ended September 30, 2018
Amounts included in contract liabilities at the beginning of the period
 
$

 
$

Performance obligations satisfied in previous period
 

 

Performance obligations satisfied in current period
 
53,021

 
177,172

Total product revenue
 
$
53,021

 
$
177,172

The following table presents changes in the Company’s contract liabilities from December 31, 2017 to September 30, 2018:
 
 
Balance as of
December 31,
2017
 
Additions
 
Deductions
 
ASC 606 Adjustment
 
Balance as of
September 30,
2018
Deferred Revenue
 
$
11,891

 
$
4,706

 
$

 
$
(3,937
)
 
$
12,660

Schedule of New Accounting Pronouncements and Changes in Accounting Principles
The impact of adoption using the modified retrospective method on the Company’s consolidated financial statements is as follows:

i.Consolidated balance sheets
 
 
Impact of changes in accounting policies
 
 
As reported September 30,
2018
 
Adjustments
 
As reported Balances without adoption of Topic 606
Assets
 
 

 
 
 
 
Current assets:
 
 

 
 
 
 
Cash and cash equivalents
 
$
206,913

 
$

 
$
206,913

Marketable securities
 
42,491

 

 
42,491

Trade receivables, net
 
42,197

 

 
42,197

Inventory
 
13,660

 
(84
)
 
13,576

Prepaid expenses and other current assets
 
8,020

 

 
8,020

Total current assets
 
313,281

 
(84
)
 
313,197

Fixed assets, net
 
8,805

 

 
8,805

Intangible assets, net
 
604,612

 

 
604,612

Goodwill
 
100,309

 

 
100,309

Deposits and other assets
 
1,620

 

 
1,620

Total assets
 
$
1,028,627

 
$
(84
)
 
$
1,028,543

Liabilities and stockholders’ equity
 
 

 
 
 
 
Current liabilities:
 
 

 
 
 
 
Accounts payable and accrued expenses
 
$
102,788

 
$
(794
)
 
$
101,994

Current portion of long-term debt
 
6,667

 

 
6,667

Deferred revenue
 
2,004

 
5,120

 
7,124

Other current liabilities
 
3,463

 

 
3,463

Total current liabilities
 
114,922

 
4,326

 
119,248

Deferred revenue - long-term
 
11,156

 

 
11,156

Long-term debt
 
144,258

 

 
144,258

Contingent consideration payable
 
218,700

 

 
218,700

Deferred consideration payable
 
38,200

 

 
38,200

Deferred tax liability
 
115,200

 

 
115,200

Other long-term liabilities
 
101

 

 
101

Total liabilities
 
642,537

 
4,326

 
646,863

 
 
 
 
 
 
 
Stockholders’ equity:
 
 

 
 
 
 
Common stock
 
51

 

 
51

Additional paid-in capital
 
1,275,004

 

 
1,275,004

Accumulated other comprehensive income
 
1,628

 

 
1,628

Accumulated deficit
 
(890,593
)
 
(4,410
)
 
(895,003
)
Total stockholders’ equity
 
386,090

 
(4,410
)
 
381,680

Total liabilities and stockholders’ equity
 
$
1,028,627

 
$
(84
)
 
$
1,028,543







ii.Consolidated statements of operations
 
 
Impact of changes in accounting policies
Three Months Ended
 
 
As reported for the period ended September 30,
2018
 
Adjustments
 
As reported Balances without adoption of Topic 606
Revenues:
 
 

 
 
 
 

Net product revenue
 
$
53,021

 
$
(834
)
 
$
52,187

Collaboration and grant revenue
 
570

 

 
570

Total revenues
 
53,591

 
(834
)
 
52,757

Operating expenses:
 
 

 
 
 
 

Cost of product sales, excluding amortization of acquired intangible asset
 
3,292

 
(17
)
 
3,275

Amortization of acquired intangible asset
 
5,793

 

 
5,793

Research and development
 
54,368

 

 
54,368

Selling, general and administrative
 
38,368

 

 
38,368

Total operating expenses
 
101,821

 
(17
)
 
101,804

Loss from operations
 
(48,230
)
 
(817
)
 
(49,047
)
Interest expense, net
 
(3,118
)
 

 
(3,118
)
Other expense, net
 
734

 

 
734

Loss before income tax expense
 
(50,614
)
 
(817
)
 
(51,431
)
Income tax expense
 
(355
)
 

 
(355
)
Net loss attributable to common stockholders
 
$
(50,969
)
 
$
(817
)
 
$
(51,786
)
 
 
Impact of changes in accounting policies
Year to Date
 
 
As reported for the period ended September 30,
2018
 
Adjustments
 
As reported Balances without adoption of Topic 606
Revenues:
 
 

 
 
 
 

Net product revenue
 
$
177,172

 
$
(1,059
)
 
$
176,113

Collaboration and grant revenue
 
1,224

 

 
1,224

Total revenues
 
178,396

 
(1,059
)
 
177,337

Operating expenses:
 
 

 
 
 
 

Cost of product sales, excluding amortization of acquired intangible asset
 
8,909

 
(84
)
 
8,825

Amortization of acquired intangible asset
 
16,815

 

 
16,815

Research and development
 
118,337

 

 
118,337

Selling, general and administrative
 
104,882

 

 
104,882

Total operating expenses
 
248,943

 
(84
)
 
248,859

Loss from operations
 
(70,547
)
 
(975
)
 
(71,522
)
Interest expense, net
 
(9,306
)
 

 
(9,306
)
Other income, net
 
1,066

 

 
1,066

Loss before income tax expense
 
(78,787
)
 
(975
)
 
(79,762
)
Income tax expense
 
(964
)
 

 
(964
)
Net loss attributable to common stockholders
 
$
(79,751
)
 
$
(975
)
 
$
(80,726
)

iii.Consolidated statements of comprehensive loss
 
 
Impact of changes in accounting policies
Three Months Ended
 
 
As reported for the period ended September 30,
2018
 
Adjustments
 
As reported Balances without adoption of Topic 606
Net loss
 
$
(50,969
)
 
$
(817
)
 
$
(51,786
)
Other comprehensive loss:
 
 

 
 
 
 

Unrealized gain on marketable securities, net of tax
 
33

 

 
33

Foreign currency translation loss
 
(260
)
 

 
(260
)
Comprehensive loss
 
$
(51,196
)
 
$
(817
)
 
$
(52,013
)
 
 
Impact of changes in accounting policies
Year to Date
 
 
As reported for the period ended September 30,
2018
 
Adjustments
 
As reported Balances without adoption of Topic 606
Net loss
 
$
(79,751
)
 
$
(975
)
 
$
(80,726
)
Other comprehensive loss:
 
 

 
 
 
 

Unrealized loss on marketable securities, net of tax
 
(50
)
 

 
(50
)
Foreign currency translation loss
 
(2,291
)
 

 
(2,291
)
Comprehensive loss
 
$
(82,092
)
 
$
(975
)
 
$
(83,067
)

iv.Consolidated statements of cash flows
 
 
Impact of changes in accounting policies
 
 
As reported for the period ended September 30,
2018
 
Adjustments
 
Balances without adoption of Topic 606
Cash flows from operating activities
 
 

 
 
 
 

Net loss
 
$
(79,751
)
 
$
(975
)
 
$
(80,726
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 

 
 
 
 

Depreciation and amortization
 
19,316

 

 
19,316

Change in valuation of warrant liability
 
3

 

 
3

Non-cash interest expense
 
5,563

 

 
5,563

Loss on disposal of asset
 
2

 

 
2

Amortization of premiums and accretion of discounts on investments, net
 
(354
)
 

 
(354
)
Amortization of debt issuance costs
 
390

 

 
390

Share-based compensation expense
 
24,773

 

 
24,773

Unrealized foreign currency transaction gain
 
(977
)
 

 
(977
)
Changes in operating assets and liabilities:
 
 

 
 
 
0

Inventory, net
 
(3,252
)
 
(84
)
 
(3,336
)
Prepaid expenses and other current assets
 
(1,301
)
 

 
(1,301
)
Trade receivables, net
 
(2,681
)
 

 
(2,681
)
Deposits and other assets
 
(385
)
 

 
(385
)
Accounts payable and accrued expenses
 
18,606

 
(794
)
 
17,812

Other liabilities
 
1,617

 

 
1,617

Deferred revenue
 
5,933

 
1,853

 
7,786

Net cash used in operating activities
 
(12,498
)
 

 
(12,498
)
Cash flows from investing activities
 
 

 
 
 
 

Purchases of fixed assets
 
(2,489
)
 

 
(2,489
)
Purchases of marketable securities
 
(28,656
)
 

 
(28,656
)
Sale and redemption of marketable securities
 
65,923

 

 
65,923

Acquisition of product rights

 
(3,903
)
 

 
(3,903
)
Business acquisition, net of cash acquired
 
(48,892
)
 

 
(48,892
)
Net cash (used in) / provided by investing activities
 
(18,017
)
 

 
(18,017
)
Cash flows from financing activities
 
 

 
 
 
 

Proceeds from exercise of options
 
8,631

 

 
8,631

Net proceeds from public offerings
 
117,915

 

 
117,915

Proceeds from shares issued under employee stock purchase plan
 
1,299

 

 
1,299

Net cash provided by financing activities
 
127,845

 

 
127,845

Effect of exchange rate changes on cash
 
(2,209
)
 

 
(2,209
)
Net increase in cash and cash equivalents
 
95,121

 

 
95,121

Cash and cash equivalents, beginning of period
 
111,792

 

 
111,792

Cash and cash equivalents, end of period
 
$
206,913

 
$

 
$
206,913